| 三阴性乳腺癌化疗进展 |
| |
| 引用本文： | 倪晨,李婷,吴振华,胡夕春. 三阴性乳腺癌化疗进展[J]. 中国癌症杂志, 2014, 24(4): 316-320. DOI: 10.3969/j.issn.1007-3969.2014.04.013 |
| |
| 作者姓名： | 倪晨 李婷 吴振华 胡夕春 |
| |
| 作者单位： | 复旦大学附属肿瘤医院肿瘤内科，复旦大学上海医学院肿瘤学系，上海 200032 |
| |
| 基金项目： | 国家自然科学基金面上项目(No：81372846)；上海市卫生局科研项目(No：沪卫科教201049) |
| |
| 摘 要： | 三阴性乳腺癌作为乳腺癌的一种特殊亚型，对内分泌治疗和现有靶向治疗无效，并且通常复发较早、进展迅速、预后较差。现就三阴性乳腺癌的分子分型及其临床价值、化疗药物和化疗方案以及化疗和潜在的新靶点药物联合方面的最新进展作一综述。
|
| 关 键 词： | 三阴性乳腺癌 分子分型 新辅助化疗 辅助化疗 姑息化疗 |
Progress on chemotherapy for triple negative breast cancer |
| |
| NI Chen,LI Ting,WU Zhen-hua,HU Xi-chun. Progress on chemotherapy for triple negative breast cancer[J]. China Oncology, 2014, 24(4): 316-320. DOI: 10.3969/j.issn.1007-3969.2014.04.013 |
| |
| Authors: | NI Chen LI Ting WU Zhen-hua HU Xi-chun |
| |
| Affiliation: | Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China |
| |
| Abstract: | Triple negative breast cancer (TNBC), as a special molecular subtype of breast cancer, is nonresponsive to endocrine therapy or commercially available targeted therapy. It is characterized by early recurrence, rapid progression and poor prognosis. This systemic and comprehensive overview was focused on recent progress on molecular subtyping of triple negative breast cancer and its possible clinical value, chemotherapeutic agents and chemotherapy regimens, and combination of chemotherapy with potential molecular targeting agents. |
| |
| Keywords: | Triple negative breast cancer Molecular subtypes Neoadjuvant chemotherapy Adjuvant chemotherapy Palliative chemotherapy |
| 本文献已被 CNKI 等数据库收录！ |
| 点击此处可从《中国癌症杂志》浏览原始摘要信息 |
|
点击此处可从《中国癌症杂志》下载全文 |
